Can I breastfeed while using the Xulane (ethinyl estradiol/norelgestromin) contraceptive patch?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Breastfeeding While Using Xulane Patches

You should consider an alternative method of birth control until you are ready to stop breastfeeding, as Xulane (a combined hormonal contraceptive patch) may decrease milk production and small amounts of hormones pass into breast milk. 1

Key Concerns with Combined Hormonal Contraceptives During Breastfeeding

Timing Restrictions

  • Combined hormonal contraceptives like Xulane should not be used during the first 3 weeks postpartum (absolute contraindication) due to increased risk of venous thromboembolism 2, 3
  • Generally should not be used during the fourth week postpartum because of concerns about potential negative effects on breastfeeding performance 2
  • Combined hormonal contraceptives can be started 6-8 weeks after delivery if breastfeeding, though this remains suboptimal 4

Impact on Milk Supply

  • Hormonal birth control methods containing estrogen, like Xulane, may decrease the amount of milk you make 1
  • The patch delivers ethinyl estradiol systemically, which can suppress lactation 5, 2
  • You will be exposed to about 60% more estrogen with Xulane compared to a typical 35-microgram birth control pill, potentially increasing the risk of reduced milk production 1

Hormone Transfer to Infant

  • A small amount of hormones from the Xulane patch may pass into your breast milk 1
  • While long-term follow-up studies of children breastfed by mothers using oral contraceptives containing 50 micrograms ethinyl estradiol showed no adverse effects on development up to 8 years of age, mothers using these contraceptives lactated for significantly shorter periods 6

Recommended Alternatives for Breastfeeding Women

Progestin-Only Methods (Preferred)

  • Progestin-only contraceptive implants (Nexplanon) are highly effective and safe during breastfeeding, with studies showing no effects on breastfeeding performance or infant health and growth 5, 7
  • Immediate postpartum LARC (long-acting reversible contraception) methods do not negatively influence lactation and should be encouraged 7
  • Progestin-only methods are the only acceptable hormonal contraceptives during the first 6 weeks postpartum 8

Important Caveat for Progestin-Only Pills

  • In Latino populations of breastfeeding women, progestin-only oral contraceptives were associated with a 2-3 fold increased risk of developing diabetes in women with a history of gestational diabetes 4
  • This finding has not been confirmed in non-breastfeeding women or other populations 8

Non-Hormonal Options

  • Copper IUD (highly effective, no hormonal effects on lactation) 5
  • Barrier methods (condoms, diaphragm) 5

Clinical Bottom Line

The FDA label for Xulane explicitly states: "Consider another method of birth control until you are ready to stop breastfeeding." 1 This recommendation is based on the dual concerns of reduced milk production from estrogen exposure and hormone transfer to the infant. If you need contraception while breastfeeding, progestin-only methods (particularly LARC devices like the implant or levonorgestrel IUD) provide highly effective alternatives without compromising lactation 5, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.